Petra Von Stein

Title: Petra Von Stein: Innovator in Oligonucleotide Therapeutics

Introduction

Petra Von Stein is a prominent inventor based in Upplands Väsby, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. With a total of seven patents to her name, her work focuses on innovative methods for treating various medical conditions.

Latest Patents

Among her latest patents is a method for the prevention of colectomy, which addresses chronic active ulcerative colitis in patients who do not respond adequately to traditional anti-inflammatory therapies. This method involves administering an effective exposure of an oligonucleotide with a specific sequence, ensuring that it is not combined with corticosteroids or glucocorticosteroids. Another notable patent involves identifying biologically active oligonucleotides that can modulate the immune system. This invention outlines methods for analyzing the tertiary structural types of oligonucleotides in a phosphate-buffered saline solution, with applications in treating inflammatory, autoimmune, infectious, neurodegenerative diseases, and cancer.

Career Highlights

Petra has worked with several companies, including Index Pharmaceuticals AB and Index Diagnostics AB. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.

Collaborations

Throughout her career, Petra has collaborated with notable colleagues, including Oliver Von Stein and Charlotte Admyre. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in her field.

Conclusion

Petra Von Stein's contributions to oligonucleotide therapeutics exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a key figure in the biotechnology industry.